insights_auto
Why is EDIT down 3,39%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,71 US$
arrow_downward
-3,39%(-0,060) 1D
1,77 US$
arrow_upward
+3,36% (+0,058)bedtimeAfter hours
Closed: 19 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,80 US$
High
1,83 US$
Low
1,70 US$
Mkt. cap
263,92 მლნ.
Avg. vol.
2,38 მლნ.
Volume
0,00
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,80 US$
High
1,83 US$
Low
1,70 US$
Mkt. cap
263,92 მლნ.
Avg. vol.
2,38 მლნ.
Volume
0,00
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
FOREX.com
·
16 წუთის წინ
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
FXStreet
·
8 საათის წინ
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
7 საათის წინ
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
·
5 საათის წინ
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc